Fox News: Updated Data from Ongoing Phase 3 Trials Support the Continued Study of Vectibix(R) (panitumumab) in Combination with Standard Chemotherapy

[riky]

Updated Data from Ongoing Phase 3 Trials Support the Continued Study of Vectibix(R) (panitumumab) in Combination with Standard Chemotherapy
     

Phase 2 Data Corroborate the Role of the KRAS Biomarker in
Advanced Colorectal Cancer

   Abstract Numbers 4064, 4034, 4127<img src="You are not allowed to view links. Register or Login" height="1" width="1"/><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
     

You are not allowed to view links. Register or Login